Blood test study seeks clues in liver disease
NCT ID NCT04199910
First seen May 05, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study looks at levels of a specific cholesterol-related substance (4beta-hydroxycholesterol) in people with liver cirrhosis. Researchers will compare these levels with those in patients with pneumonia, Crohn's disease, or ulcerative colitis. The goal is to understand how cirrhosis and its medications affect this marker. About 120 participants are being recruited from Oulu University Hospital.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oulu University Hospital
Oulu, 90029 OYS, Finland
Conditions
Explore the condition pages connected to this study.